Genuine	O
monovalent	O
ligands	O
of	O
TrkA	O
nerve	O
growth	O
factor	O
receptors	O
reveal	O
a	O
novel	O
pharmacological	O
mechanism	O
of	O
action	O
.	O

Developing	O
small	O
molecule	O
agonistic	O
ligands	O
for	O
tyrosine	O
kinase	O
receptors	O
has	O
been	O
difficult	O
,	O
and	O
it	O
is	O
generally	O
thought	O
that	O
such	O
ligands	O
require	O
bivalency	O
.	O

Moreover	O
,	O
multisubunit	O
receptors	O
are	O
difficult	O
to	O
target	O
,	O
because	O
each	O
subunit	O
contributes	O
to	O
ligand	O
affinity	O
,	O
and	O
each	O
subunit	O
may	O
have	O
distinct	O
and	O
sometimes	O
opposing	O
functions	O
.	O

Here	O
,	O
the	O
nerve	O
growth	O
factor	O
receptor	O
subunits	O
p75	O
and	O
the	O
tyrosine	O
kinase	O
TrkA	O
were	O
studied	O
using	O
artificial	O
ligands	O
that	O
bind	O
specifically	O
to	O
their	O
extracellular	B-Immaterial_anatomical_entity
domain	O
.	O

Bivalent	O
TrkA	O
ligands	O
afford	O
robust	O
signals	O
.	O

However	O
,	O
genuine	O
monomeric	O
and	O
monovalent	O
TrkA	O
ligands	O
afford	O
partial	O
agonism	O
,	O
activate	O
the	O
tyrosine	O
kinase	O
activity	O
,	O
cause	O
receptor	O
internalization	O
,	O
and	O
induce	O
survival	O
and	O
differentiation	O
in	O
cell	B-Cell
lines	I-Cell
and	O
primary	B-Cell
neurons	I-Cell
.	O

Monomeric	O
and	O
monovalent	O
TrkA	O
ligands	O
can	O
synergize	O
with	O
ligands	O
that	O
bind	O
the	O
p75	O
subunit	O
.	O

However	O
,	O
the	O
p75	O
ligands	O
used	O
in	O
this	O
study	O
must	O
be	O
bivalent	O
,	O
and	O
monovalent	O
p75	O
ligands	O
have	O
no	O
effect	O
.	O

These	O
findings	O
will	O
be	O
useful	O
in	O
designing	O
and	O
developing	O
screens	O
of	O
small	O
molecules	O
selective	O
for	O
tyrosine	O
kinase	O
receptors	O
and	O
indicate	O
that	O
strategies	O
for	O
designing	O
agonists	O
of	O
multisubunit	O
receptors	O
require	O
consideration	O
of	O
the	O
role	O
of	O
each	O
subunit	O
.	O

Last	O
,	O
the	O
strategy	O
of	O
using	O
anti	O
-	O
receptor	O
mAbs	O
and	O
small	O
molecule	O
hormone	O
mimics	O
as	O
receptor	O
ligands	O
could	O
be	O
applied	O
to	O
the	O
study	O
of	O
many	O
other	O
heteromeric	O
cell	B-Cellular_component
surface	I-Cellular_component
receptors	O
.	O

